What you are referring to had nothing to do with a director of Allegiance. It was a consultant to Allegiance and as far as I know Allegiance did not invest in ICP for over a year now.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
